The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
Experts also underscored the growing role of technologies such as tele-neurorehabilitation, robotics, and AI-driven therapies in improving recovery outcomes
These results were consistent across all clinically relevant patient subgroups regardless of key patient characteristics like age or sex, the cause of stroke or the severity of the stroke
Millions of stroke survivors across the world may soon have a new defense
The study showed a significant 29% reduction in the risk for heart attack, stroke and death from any cause in the Wegovy users
_256_384.jpg)
Emcure and Dhoni, through a video, urge everyone to be aware about symptoms of stroke and educate at least one person for identification of stroke and spread its awareness
Strokes are affecting approximately 1.8 million people annually
This marks the first FDA approval of an AI-based brain disorder analysis solution from Korea
Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge
Economic analysis of cost of Vall d’Hebron University Hospital Stroke Unit shows direct-to-angio stroke pathway can save more than USD 3,000 per patient
Subscribe To Our Newsletter & Stay Updated
